Jack Kaye Net Worth - Insider Trades and Bio as of Jun 3, 2026

QUREuniQure N.V.SEC CIK: 0001376099

Estimated Net Worth

$2.25 Million

Last Updated: May 19, 2026 11:31 PM EST

Transaction Summary

Total Transactions52

Buy-Sell Ratio0.15

Buy Transactions2

Sell Transactions13

Transaction Volume

Total Volume-$1.30M

Net Volume$1.36M

Buy Volume$29.71K

Sell Volume-$1.33M

Trade Analysis

AVG Trade Size-$32.58K

Largest Trade$15.02K

Most Active MonthJun

Most Active Year2025

Trading Sentiment

OverallBullish

Recent TradeSelling

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Jack Kaye has an estimated net worth of $2.25 Million. This is based on reported shares across multiple companies, which include uniQure N.V., DYADIC INTERNATIONAL INC, and KERYX BIOPHARMACEUTICALS INC.

2025 was Jack Kaye's most active year for acquiring shares with 10 total transactions. Jack Kaye's most active month to acquire stocks was the month of May. 2025 was Jack Kaye's most active year for disposing of shares, totalling 11 transactions. Jack Kaye's most active month to dispose stocks was the month of December. 2025 saw Jack Kaye paying a total of $423,434.80 for 205,047 shares, this is the most they've acquired in one year. In 2025 Jack Kaye cashed out on 160,834 shares for a total of $1,247,935.35, their largest year based on trade value.

Holdings & Transactions

QUREuniqure n.v.

Updated: Jan 12, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.24	6.39K	$23.34	-$50.42K	Jan 12, 2026	20.44K	Sale	Scheduled	Jan 09	View
From 4	-0.66	38.81K	$20.11	-$793.98K	Nov 06, 2025	20.44K	Sale	Scheduled	Nov 04	View
From 4	-0.09	2.11K	$14.45	-$30.52K	Jun 24, 2025	20.44K	Sale	—	Jun 20	View
From 4	1.62	23.60K	—	—	Jun 13, 2025	38.18K	Grant	—	Jun 11	View
From 4	3.68	23.92K	—	—	Jun 21, 2024	30.42K	Grant	—	Jun 19	View
From 4	-0.25	2.22K	$5.16	-$11.44K	Jun 17, 2024	6.50K	Sale	—	Jun 13	View
From 5	-0.74	25.40K	—	—	Feb 06, 2024	8.72K	Grant	—	Jun 23	View
From 4	0.85	23.48K	$18.93	-$43.16K	Jun 20, 2023	51.18K	Grant	—	Jun 13 - 16	View
From 4	-0.01	384.00	$19.99	-$7.68K	Mar 01, 2023	27.70K	Sale	—	Feb 27	View
From 4	1.42	26.89K	—	—	Jun 17, 2022	45.89K	Grant	—	Jun 15	View
From 4	-0.03	600.00	$16.76	-$10.06K	Mar 02, 2022	19.00K	Sale	—	Feb 28	View
From 4	0.23	4.18K	—	—	Feb 28, 2022	22.25K	Grant	—	Feb 24	View
From 4	-0.03	504.00	$37.60	-$18.95K	Mar 04, 2021	18.07K	Sale	—	Mar 02	View
From 4	0.40	6.49K	—	—	Mar 01, 2021	22.68K	Grant	—	Feb 25	View
From 4	0.40	5.68K	—	—	Mar 02, 2020	19.81K	Grant	—	Feb 27	View
From 4	-0.05	806.00	$62.20	-$50.13K	Jan 30, 2020	14.13K	Sale	—	Jan 28	View
From 4	-0.07	1.21K	$31.31	-$37.89K	Jan 31, 2019	14.93K	Sale	—	Jan 28	View
From 4	0.66	8.53K	—	—	Jan 31, 2019	21.44K	Grant	—	Jan 25	View
From 4	-0.18	2.88K	$18.53	-$53.33K	Jan 31, 2018	12.91K	Sale	—	Jan 29	View
From 4	1.02	11.18K	—	—	Jan 30, 2018	22.18K	Grant	—	Jan 26	View
From 4	—	22.00K	—	—	Jan 31, 2017	22.00K	Grant	—	Jan 27	View
From 3	—	—	—	—	Jan 10, 2017	—	—	—	—	View

DYAIdyadic international inc

Updated: Jan 06, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.32	107.39K	—	—	Jan 06, 2026	188.60K	Options	—	Jan 02	View
From 4	-0.32	27.52K	$1.39	$0.35	Mar 07, 2025	59.65K	Options	—	Mar 05	View
From 4	1.56	89.05K	—	—	Jan 07, 2025	146.22K	Options	—	Jan 02	View
From 4	2.71	91.08K	—	—	Jan 04, 2024	124.67K	Options	—	Jan 02 - 03	View
From 4	—	79.67K	—	—	Jan 05, 2023	79.67K	Grant	—	Jan 03	View
From 4	—	25.00K	—	—	Jun 14, 2022	25.00K	Grant	—	Jun 10	View
From 4	—	52.50K	—	—	Jan 05, 2022	52.50K	Grant	—	Jan 03	View
From 4	—	52.50K	—	—	Jan 06, 2021	52.50K	Grant	—	Jan 04	View
From 4	—	75.00K	—	—	Jan 03, 2020	75.00K	Grant	—	Jan 02	View
From 4	—	25.00K	—	—	Jun 27, 2019	25.00K	Grant	—	Jun 25	View
From 3	—	—	—	—	Feb 13, 2019	72.71K	—	—	—	View

keryx biopharmaceuticals inc

Updated: Jun 18, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.53	40.00K	—	—	Jun 18, 2015	115.00K	Grant	—	Jun 17	View
From 4	0.62	40.00K	—	—	Jun 26, 2014	105.00K	Grant	—	Jun 24	View
From 4	-0.19	15.00K	$9.13	-$136.95K	Sep 09, 2013	65.00K	Grant	—	Sep 06	View
From 4	0.62	40.00K	—	—	Jun 21, 2013	105.00K	Grant	—	Jun 19	View
From 4	-0.13	10.00K	$1.81	-$18.10K	Feb 15, 2013	65.00K	Grant	—	Jun 27	View
From 4	0.67	40.00K	—	—	Jun 22, 2012	100.00K	Grant	—	Jun 20	View
From 4	-0.14	9.72K	$2.65	-$25.76K	Jan 04, 2012	60.00K	Grant	—	Jan 03	View
From 4	-0.55	86.68K	$2.42	-$209.77K	Dec 19, 2011	69.72K	Grant	—	Dec 15	View
From 4	0.28	40.00K	—	—	Jul 13, 2011	181.40K	Grant	—	Jun 22	View
From 4	-0.12	20.00K	$5.00	-$100.00K	Dec 08, 2010	141.40K	Sale	—	Dec 06	View
From 4	-0.13	25.00K	$5.02	-$125.50K	Oct 01, 2010	161.40K	Sale	—	Sep 29	View
From 4	0.23	40.00K	—	—	Jun 18, 2010	211.40K	Grant	—	Jun 16	View
From 4	—	30.00K	—	—	Sep 22, 2009	30.00K	Grant	—	Sep 19	View
From 4	0.88	85.00K	—	—	Jun 18, 2009	181.40K	Grant	—	Jun 16 - 17	View
From 4	0.57	35.00K	$0.43	$15.02K	May 22, 2009	96.40K	Purchase	—	May 22	View
From 4	42.86	60.00K	—	—	Nov 18, 2008	61.40K	Grant	—	Nov 14	View
From 4	—	10.00K	—	—	Jun 20, 2008	10.00K	Grant	—	Jun 18	View
From 4	—	11.40K	$10.50	$14.70K	Jun 22, 2007	11.40K	Purchase	—	Jun 19 - 21	View
From 3	—	—	—	—	Sep 22, 2006	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions